(Q51887291)

16 April 2018

title

Body composition in psychotic disorders: a general population survey. (English)

1 reference

16 April 2018

1 reference

3

1 reference

16 April 2018

author name string

S E Saarni

1

1 reference

16 April 2018

S I Saarni

2

1 reference

16 April 2018

M Heliövaara

4

1 reference

16 April 2018

J Perälä

5

1 reference

16 April 2018

J Suvisaari

6

1 reference

16 April 2018

J Lönnqvist

7

1 reference

16 April 2018

language of work or name

English

0 references

publication date

20 August 2008

1 reference

16 April 2018

published in

Psychological Medicine

1 reference

16 April 2018

volume

39

1 reference

16 April 2018

issue

5

1 reference

16 April 2018

page(s)

801-810

1 reference

16 April 2018

Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population--results from the Health 2000 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Comparison of body composition methods: a literature analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Lifetime prevalence of psychotic and bipolar I disorders in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Excess mortality in bipolar and unipolar disorder in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Prevalence of overweight and obesity in the United States, 1999-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

The disease burden associated with overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Is dietary pattern of schizophrenia patients different from healthy subjects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Actual Causes of Death in the United States, 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Mental disorders and cause-specific mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

The public health impact of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Mortality among patients with schizophrenia and reduced psychiatric hospital care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Are females at special risk of obesity if they become psychotic? The longitudinal Northern Finland 1966 Birth Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Obesity among individuals with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Sarcopenia: effects on body composition and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Physical illness and lifestyle risk factors in people with their first presentation of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Pituitary volume in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Changes in body mass index for individuals with and without schizophrenia, 1987–1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

Comparison of the body fluid levels in healthy individuals and those with schizophrenia in Japan: using the bioelectrical impedance method

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Associations between aortic calcification and components of body composition in elderly men

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Are mood disorders and obesity related? A review for the mental health professional.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Waist Circumference, BMI, Smoking, and Mortality in Middle-Aged Men and Women

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

The unhealthy lifestyle of people with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Depressive Symptoms and Stressful Life Events Predict Metabolic Syndrome Among Middle-Aged Women: A comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Atypical antipsychotics and glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Metabolic syndrome in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Metabolic disturbance in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291708004194

7 January 2021

10.1017/S0033291708004194

Identifiers

DOI

1 reference

16 April 2018

PubMed ID

18713488

1 reference

16 April 2018